Skip to content

The use of cell salvage in women undergoing Cesarean section for Central placenta

The use of cell salvage in women undergoing Cesarean section for Central placenta

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OIC-16008810
Enrollment
Unknown
Registered
2016-07-09
Start date
2016-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central placenta

Interventions

group cell salvage :cell salvage

Sponsors

Wenzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: patients with diagnosis invasive central placenta used MRI or ultrasound who undergoing CS elective or emergency

Exclusion criteria

Exclusion criteria: patients refused blood type with Rh- history of transfusion Hb less than 70g/L has enrolled other studies

Design outcomes

Primary

MeasureTime frame
volume of autologous blood transfusion;volume of allogenetic RBC;cost related transfusion;

Contacts

Public ContactLi Jian

Wenzhou People's Hospital

313591073@qq.com+86 13758431800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026